Fertility in Childhood Cancer Survivors — What Parents Ask at Diagnosis, What Survivors Ask Later

Sometimes, and not always. Fertility is affected when treatment reaches the ovaries, the testes, or the pituitary gland that signals to them. Radiation to the pelvis, radiation to the whole body before a transplant, and some chemotherapy regimens carry the highest risk. Treatment to an arm, a leg or the chest usually carries none.

That is the honest shape of the answer, and it is worth holding on to, because “cancer treatment causes infertility” is repeated so often that many families assume the worst before anyone has looked at the plan. The plan is what decides it. Two children with the same diagnosis can leave treatment with completely different fertility outlooks, simply because one had a field that included the pelvis and the other did not.

Four things decide the risk: which part of the body was in the radiation field, the total dose that reached the ovaries or testes, which chemotherapy was given alongside the radiation, and how old the child was at the time. ASTRO and NCCN survivorship guidance sort survivors into low, intermediate and high risk on exactly those factors, rather than giving a single figure — because the range across children is genuinely that wide.

Parents ask in week one, when treatment has to start and preservation options are still open. Survivors ask at twenty-five, when the question is what is actually there now. The biology is the same. The next steps are completely different, and both deserve a straight answer rather than a reassurance.

Most pages on this subject pick one audience and lose the other. A parent reading about ovarian reserve testing at twenty-five gets nothing useful for Monday morning. A twenty-five-year-old reading about sperm banking before treatment is reading about a door that closed years ago. So this page answers twice.

There is no single date. Before treatment there should be a baseline conversation. After treatment, puberty itself is the first marker — whether it starts on time and completes. Hormone blood tests are usually added around age ten or eleven, and formal fertility testing in the mid-to-late teens.

Think of it as a set of checkpoints spread over years, rather than one appointment you either attend or miss. Each checkpoint answers a different question, and the earlier ones are mostly there to give the later ones something to compare against.

• Before treatment starts — a fertility conversation with the treating team, and for a teenager past puberty, a semen analysis or baseline hormone bloods where there is time to do them.
• The first years after treatment — height, growth velocity and general development at every follow-up visit. Nothing fertility-specific yet, but the groundwork for it.
• From around age ten or eleven — puberty is tracked deliberately, with hormone blood tests added on a set interval. Earlier if the pelvis, the whole body or the pituitary area was treated.
• Mid-to-late teens — formal testing offered once the young person can take part in the conversation: semen analysis for young men, hormone and ovarian reserve testing for young women.
• When a family is actually being considered — repeat testing and a referral to a fertility specialist, because results from five years earlier are a starting point rather than an answer.

Ask for these checkpoints in writing at the end-of-treatment handover. Families who leave with a dated schedule spend far less of the next decade wondering whether something has been missed.

They share the same hormone pathway. The pituitary gland drives growth and puberty and signals to the ovaries and testes, so a treatment that affects one often shows up in the others. That is why height charts and puberty timing are read as early fertility information, years before any fertility test is done.

In practice this means the first sign of a fertility issue is often not a fertility test at all. It is a growth chart flattening, a puberty that has not started when peers have moved on, or a puberty that begins and then stalls. Those changes are why height is measured at every single follow-up visit and why the measurement is plotted rather than just recorded.

Growth itself can be affected in more than one way. Spinal radiation can reduce sitting height because the treated vertebrae grow less, and brain-directed radiation that includes the pituitary area can reduce growth hormone. Both are managed — with endocrinology input, and sometimes with hormone treatment a specialist prescribes — but only if someone is measuring. WHO and NCCN survivorship guidance both frame this as risk-based monitoring built from the treatment actually received, not from the diagnosis on the file.

• “What dose will reach the ovaries or testes?” — the single most useful question a parent can ask on planning day, and one the planning team can answer from the plan itself.
• “Can anything be shielded, moved or banked before we start?” — ask before the first session, because most of these options close once treatment is under way.
• “Will you write the treatment summary and the follow-up schedule down?” — fields, total dose, chemotherapy given, dates. Keep your own copy; the hospital’s copy is not always the one you can reach at twenty-five.
• “Am I due for fertility testing yet?” — for the young adult. Testing is a normal part of survivorship care and does not have to wait until you are trying for a baby.
• “Do I still need contraception?” — usually yes. Reduced fertility is not the same as no fertility, and survivors do conceive unexpectedly.
• “Should I freeze eggs or sperm now, for later?” — a reasonable question in your twenties if testing shows reduced reserve, and one a fertility specialist can answer properly.

• If the plan includes the brain and spine, the fertility question sits alongside several others — Craniospinal Radiation in Children: What Parents Should Expect walks through what that treatment involves.
• Fertility is one late effect among several, and second-cancer screening is another — Second Cancers After Childhood Radiation explains what is screened and from when.
• While treatment is running, the classroom question is usually louder than the fertility one — Going Back to School During and After Radiation covers attendance, catching up and what to tell the school.
• Brothers and sisters are carrying this too, often quietly — Siblings and Family Life During a Child’s Cancer Treatment is written for the rest of the household.
• For the full picture of how treatment is planned, delivered at NABH-accredited partner centres and coordinated by our team, see Radiation Therapy at CION Cancer Clinics.

Not sure whether this applies to your child, or to you? Book a free consultation and a radiation oncologist will go through the treatment plan or the treatment summary with you, field by field. Or call 1800 202 8726.